VA gets new lung-imaging tool to diagnose veteran respiratory disease
H.R. 9666 — AIR CARE for Vets Act of 2026 · Filed by Juan Ciscomani (R-AZ) · 2 cosponsors · Introduced Jul 14, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the VA to run a 5-year pilot program using FDA-approved 4D lung imaging software to detect respiratory disorders and lung disease in veterans. The VA will lease the software from a private developer, spend up to $5 million per year (2027–2031), and report back to Congress on whether it works. Veterans with lung problems get earlier, better diagnosis; the software company gets a guaranteed federal customer.
Why we flagged it
The bill's core function is establishing a time-limited, evidence-based pilot to test a specific diagnostic technology for a veteran population. It is not a permanent entitlement, not a broad deregulation, and not a carve-out — it is a targeted pilot with built-in evaluation and sunset.
What the text implies
- The bill does not specify competitive bidding or price controls; the VA may negotiate with a single vendor, creating potential for above-market lease rates if the software is proprietary or sole-source.
- The 5-year pilot expires before the 2-year post-pilot report is due, meaning Congress will not receive evaluation data until 2 years after the program ends — a gap that could delay scaling or termination decisions.
- FDA approval is required but the bill does not mandate VA validation or comparative effectiveness testing; the pilot may proceed with only FDA clearance, not VA-specific clinical evidence.
- The $5M/year authorization is capped but not mandatory; actual spending depends on appropriations, so the program could be underfunded or defunded mid-pilot despite the authorization.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Veterans gain access to advanced diagnostic technology for a serious health condition (respiratory disease, often service-connected); the pilot is time-limited, evidence-based (requires FDA approval and a post-pilot report), and does not restrict existing VA services. The private vendor benefit is secondary and contingent on the software actually working.
Who stands to gain
- 4D lung imaging software developers/vendors
- Medical device companies with FDA-approved respiratory imaging products
Named in the bill
Department of Veterans Affairs, Food and Drug Administration, Veterans, 4D functional lung imaging software developers
Where it stands
2 cosponsors: 2 Democrats.
- Jul 14, 2026 — Introduced · Congress.gov: “Introduced in House”
- Jul 14, 2026 — Referred to House Committee on Veterans' Affairs · Congress.gov: “Referred to the House Committee on Veterans' Affairs”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,699 characters) on Jul 25, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“VA gets new lung-imaging tool to diagnose veteran respiratory disease” QuorumCivic. https://share.quorumcivic.app/bill/119/hr9666 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.